Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
28 Oct 2016 | 10:22 PM

GlaxoSmithKline Pharmaceuticals Ltd. Share Price Live (BSE)

BSE Code: 500660 | NSE Symbol: GLAXO
(-0.34 %)
28 Oct 2016 | 04:01 PM
Change company
  • Open (Rs)
  • Prev. close (Rs.)
  • High (Rs.)
  • Low (Rs.)
  • 52W H (Rs.)
  • 52W L (Rs.)
  • Volume (Rs.)
  • MCap (Rs in Cr.)

Upside Rating

Upside Rating denotes four star rating for GlaxoSmithKline Pharmaceuticals Ltd. on the basis of Earning Revision, Technical, Valuation Trends and Relative performance.
Weak interest since 2016-10-18.
Earnings Revision Trend
Analysts positive since 2016-10-18
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 2016-10-18 at a price of 2971.10.

Switch Proposals

This column provides you to switch proposals on alternative stocks against the current non performing stocks in your current holdings.
Company NameUpside RatingRisk

Risk Rating

Risk Rating denotes the sensitivity of GlaxoSmithKline Pharmaceuticals Ltd. to extrinsic factors like bad news and fall in stock market. The risk is denoted with low, medium and high ratings.
The stock is classified in the medium-risk zone since 2016-08-02.
Bear Market
Average risk positioning during market declines 
On average, the stock is likely to decline with the index.
Bad News
Slight market sanction in case of specific pressure 
When the stock's pressure is specific, the market sanction on average is 1.69%.
Low sensitivity to SENSEX30 
For 1% of index variation, the stock varies on average by 0.48%.
Fair correlation to SENSEX30 
0.4038 of stock movements are explained by index variations.
Value at Risk
The medium term value at risk is estimated at INR 249.21 or 8.441% 
The value at risk is estimated at INR 249.21. The risk is therefore 8.441. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%%.

Trend Signal & Target Price

The trend is an indicative of the price trend expected in GlaxoSmithKline Pharmaceuticals Ltd. The target price reflects a combination of fair fundamental price and technical considerations.
Trend Signal
Target Price

Key Facts

Key Facts aggregates the key company related figures such as PE ratios, dividend yields and 4 week stock performance for GlaxoSmithKline Pharmaceuticals Ltd.
Mkt Cap in $bn
With a market capitalization between $1&$5bn, GLXSK.PHARMS.LTD. is considered a mid-cap stock.
G/PE Ratio
>50% premium to expected growth 
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
Estimated PE for 2019 
The estimated PE is for the year 2019.
LT Growth
Current year to 2019 annualized estimate 
The annualized growth estimate is for the current year to 2019.
Avg. No. of Analysts
Fairly followed by financial analysts 
Over the last seven weeks, an average of 7 analysts provided earnings per share estimates.
Dividend Yield
Dividend is not covered by profits 
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
4 Week Relative Performance
vs. SENSEX30 
The four week relative overperformance versus SENSEX30 is 7.250%.

Upgrades / Downgrades

Upgrades / Downgrades denotes the history of change in star ratings for GlaxoSmithKline Pharmaceuticals Ltd.
Upgraded as on 14-Oct-2016

Star Ratings is a stock selection tool which can help you choose the right stocks based on fundamental, technical and analyst recommendations. Get the complete list of stock trading tips and recommendations here.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.